Valley National Advisers’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48K | Hold |
1,000
| – | – | 0.01% | 382 |
|
|
2025
Q1 | $34K | Hold |
1,000
| – | – | 0.01% | 419 |
|
|
2024
Q4 | $39K | Hold |
1,000
| – | – | 0.01% | 379 |
|
|
2024
Q3 | $46K | Sell |
1,000
-100
| -9% | -$4.6K | 0.01% | 362 |
|
|
2024
Q2 | $59K | Hold |
1,100
| – | – | 0.01% | 369 |
|
|
2024
Q1 | $74K | Buy |
1,100
+100
| +10% | +$6.73K | 0.01% | 356 |
|
|
2023
Q4 | $62K | Buy |
+1,000
| New | +$62K | 0.01% | 376 |
|